Cite

Imatinib mesylate causes hypopigmentation in the skin.

MLA

Tsao, Anne S., et al. “Imatinib Mesylate Causes Hypopigmentation in the Skin.” Cancer, vol. 98, no. 11, Dec. 2003, pp. 2483–87. EBSCOhost, https://doi.org/10.1002/cncr.11812.



APA

Tsao, A. S., Kantarjian, H., Cortes, J., O’Brien, S., & Talpaz, M. (2003). Imatinib mesylate causes hypopigmentation in the skin. Cancer, 98(11), 2483–2487. https://doi.org/10.1002/cncr.11812



Chicago

Tsao, Anne S, Hagop Kantarjian, Jorge Cortes, Susan O’Brien, and Moshe Talpaz. 2003. “Imatinib Mesylate Causes Hypopigmentation in the Skin.” Cancer 98 (11): 2483–87. doi:10.1002/cncr.11812.